Rockefeller Capital Management
IMMU

Rockefeller Capital Management’s Immunomedics Inc IMMU Stock Holding History

Rockefeller Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-732
Closed -$62K – 3096
2020
Q3 		$62K Buy
732
+133
+22% +$6.73K ﹤0.01% 1439
2020
Q2 		$21K Sell
599
-179
-23% -$5.23K ﹤0.01% 1677
2020
Q1 		$10K Buy
+778
New +$13.1K ﹤0.01% 1756

Rockefeller Capital Management's IMMU Position: Q4 2020 in Review

Rockefeller Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 732 shares — an estimated $62K sold.

Rockefeller Capital Management first reported a position in IMMU in Q1 2020 and held it in 3 quarters. The position peaked at $62K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Rockefeller Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Rockefeller Capital Management sold 732 Immunomedics Inc shares in Q4 2020, an estimated $62K.
  • Rockefeller Capital Management first reported a position in Immunomedics Inc in Q1 2020 and held it in 3 quarters.
  • Rockefeller Capital Management's Immunomedics Inc position peaked at $62K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.